Skip to main content

Publications

featured publications
  • Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.

    Journal of cancer research and clinical oncology

    Authors: Volker Arndt, Daniela Doege, Stefan Fröhling, Peter Albers, Hana Algül, Ralf Bargou, Carsten Bokemeyer, Martin Bornhäuser, Christian H Brandts, Peter Brossart, Sara Yvonne Brucker, Tim H Brümmendorf, Hartmut Döhner, Norbert Gattermann, Michael Hallek, Volker Heinemann, Ulrich Keilholz, Thomas Kindler, Cornelia von Levetzow, Florian Lordick, Ulf Peter Neumann, Christoph Peters, Dirk Schadendorf, Stephan Stilgenbauer, Thomas Zander, Daniel Zips, Delia Braun, Thomas Seufferlein, Gerd Nettekoven, Michael Baumann

    View this publication
  • Salvage Autologous Transplant in Relapsed Multiple Myeloma: Long-Term Follow-Up of the Phase 3 GMMG ReLApsE Trial.

    Blood

    Authors: Marc-Andrea Baertsch, Jana Schlenzka, Thomas Hielscher, Marc S Raab, Sandra Sauer, Maximilian Merz, Elias K Mai, Carsten Müller-Tidow, Steffen Luntz, Anna Jauch, Peter Brossart, Martin Goerner, Stefan Klein, Bertram Glass, Peter Reimer, Ullrich Graeven, Roland Fenk, Mathias Haenel, Ivana von Metzler, Hans-Walter Lindemann, Christof Scheid, Igor-Wolfgang W Blau, Hans J Salwender, Richard Noppeney, Britta Besemer, Katja C Weisel, Hartmut Goldschmidt

    View this publication
  • Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy.

    JAMA oncology

    Authors: Jonas Saal, Markus Eckstein, Manuel Ritter, Peter Brossart, Julian Luetkens, Jörg Ellinger, Viktor Grünwald, Michael Hölzel, Niklas Klümper

    View this publication
  • The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression.

    European journal of cancer (Oxford, England : 1990)

    Authors: Jonas Saal, Markus Eckstein, Manuel Ritter, Peter Brossart, Michael Hölzel, Viktor Grünwald, Niklas Klümper

    View this publication
  • Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial.

    HemaSphere

    Authors: Elias K Mai, Axel Nogai, Henk M Lokhorst, Bronno van der Holt, Sonja Zweegman, Katja C Weisel, Sandra Croockewit, Anna Jauch, Jens Hillengass, Marian Stevens-Kroef, Marc S Raab, Annemiek Broijl, Gerard M J Bos, Peter Brossart, Paula Ypma, Christine Hanoun, Uta Bertsch, Thomas Hielscher, Hans J Salwender, Christoph Scheid, Hartmut Goldschmidt, Pieter Sonneveld

    View this publication
  • The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells.

    Cancers

    Authors: Sebastian Schlaweck, Alea Radcke, Sascha Kampmann, Benjamin V Becker, Peter Brossart, Annkristin Heine

    View this publication
  • Unleashing the potential of eHealth in outpatient cancer care for patients undergoing immunotherapy-a quantitative study considering patients' needs and current healthcare challenges.

    Frontiers in digital health

    Authors: Tobias A W Holderried, Isabel Stasik, Marie-Therese Schmitz, Friederike Schmitz, Tizian K Meyer, Leonie Stauß, Martin Kirschner, Dirk Skowasch, Jennifer Landsberg, Matthias Schmid, Peter Brossart, Martin Holderried

    View this publication
  • The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma.

    Scientific reports

    Authors: Michael Praktiknjo, Ana S Pena Solano, Farsaneh Sadeghlar, Thomas Welchowski, Matthias Schmid, Christian Möhring, Taotao Zhou, Robert Mahn, Malte B Monin, Carsten Meyer, Georg Feldmann, Peter Brossart, Cornelius van Beekum, Alexander Semaan, Hanno Matthaei, Steffen Manekeller, Alois M Sprinkart, Sebastian Nowak, Julian Luetkens, Jörg C Kalff, Christian P Strassburg, Maria A González-Carmona

    View this publication
  • Antibiotic prophylaxis during allogeneic stem cell transplantation - A comprehensive single center retrospective analysis.

    Transplantation and cellular therapy

    Authors: Charlotte K F Neuerburg, Friederike Schmitz, Marie-Therese Schmitz, Susanne Rehnelt, Martin Schumacher, Marjio Parčina, Matthias Schmid, Dominik Wolf, Peter Brossart, Tobias A W Holderried

    View this publication
  • Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports.

    Rheumatology international

    Authors: Christian R Klein, Annkristin Heine, Peter Brossart, Pantelis Karakostas, Valentin Sebastian Schäfer

    View this publication